Anguilla Tech Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Tech Gazette.

Press releases published on May 26, 2026

May 26, 2026

Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027

Indeterminate GlobeNewswire

May 26, 2026

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

May 26, 2026

Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

May 26, 2026

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Indeterminate GlobeNewswire

May 26, 2026

Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy

Indeterminate GlobeNewswire

May 26, 2026

Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions

Indeterminate GlobeNewswire

May 26, 2026

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

Indeterminate GlobeNewswire

May 26, 2026

Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026

Indeterminate GlobeNewswire

May 26, 2026

Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases for CLN-978, a CD19 T Cell Engager, and Velinotamig, a BCMA T Cell Engager

Indeterminate GlobeNewswire

May 26, 2026

Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention

Indeterminate GlobeNewswire

May 26, 2026

TRUEiGTECH Launches TruePredict to Power FIFA World Cup Sports Prediction Platforms for iGaming Operators

Indeterminate GlobeNewswire

May 26, 2026

Aurora Mobile Limited Announces First Quarter 2026 Unaudited Financial Results

Indeterminate GlobeNewswire

May 26, 2026

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026

Indeterminate GlobeNewswire

May 26, 2026

Editas Medicine Announces Proposed Public Offering

Indeterminate GlobeNewswire

May 26, 2026

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

Indeterminate GlobeNewswire

May 26, 2026

Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress

Indeterminate GlobeNewswire

May 26, 2026

Resilience Foundation to Launch The RE Governance Token

Indeterminate GlobeNewswire

May 26, 2026

BGIN BLOCKCHAIN LIMITED Launches ASIC Chip Customization Solutions Business and Completes Inaugural Customer Delivery

Indeterminate GlobeNewswire

May 26, 2026

Tycho.AI Validates Halley VTOL UAS with Successful C-UAS and One-Way Attack Demonstrations at T-REX 26-2

Indeterminate GlobeNewswire

May 26, 2026

Improbable invests $2M in Otomato to scale the first portfolio-aware intelligence layer for DeFi

Indeterminate GlobeNewswire